A trial of more than 17,000 people found semaglutide (the active drug in Ozempic/Wegovy) cut the risk of serious heart attacks and strokes by 20%, even in people without diabetes
A meaningful minority lose little or nothing
Semaglutide mimics the GLP-1 hormone in response to eating, which causes an increase in insulin production, therefore leading to better blood sugar control
Ballard, In vivo actions of IGF analogues with poor affinities for IGFBPs: metabolic and growth effects in pigs of different ages and GH responsiveness
Most users notice improved recovery and sleep within 1-2 weeks
To qualify, youll need to: Attend at least 5 out of the 6 live sessions Complete the brief before-and-after health assessments Submit results from your blood work immediately before and after the program Schedule your repeated Jumpstart within 12 months of program completion Your participation means that your anonymized data will be added to our data pool